James Urbanic

Title(s)Professor Of Clinical, Radiation Medicine and Applied Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial. JAMA Oncol. 2024 Sep 01; 10(9):1212-1219. Ross HJ, Kozono D, Wang XF, Urbanic JJ, Williams TM, Nelson GD, Carbone DP, Chung D, Robb R, Byun WY, Talabere T, DuFrane C, Bara I, Schulze K, Brockman M, Gao J, Vokes EE, Stinchcombe TE. PMID: 39052256; PMCID: PMC11273282.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    2. Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial. Int J Radiat Oncol Biol Phys. 2024 Sep 01; 120(1):149-161. Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, Wright JL, MacDonald SM, Cahlon O, Baas C, Braunstein LZ, Fang LC, Freedman GM, Jimenez RB, Kesslering CM, Mishra MV, Mutter RW, Ohri N, Rosen LR, Urbanic JJ, Jagsi R, Mitchell SA, Bekelman JE, Cella D, Study Group Investigators:. PMID: 38739047; PMCID: PMC11329347.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. A quantitative framework for patient-specific collision detection in proton therapy. J Appl Clin Med Phys. 2024 Apr; 25(4):e14247. Northway SK, Vallejo BM, Liu L, Hansen EE, Tang S, Mah D, MacEwan IJ, Urbanic JJ, Chang C. PMID: 38131514; PMCID: PMC11005990.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2024 May 01; 119(1):66-77. Valdes G, Scholey J, Nano TF, Gennatas ED, Mohindra P, Mohammed N, Zeng J, Kotecha R, Rosen LR, Chang J, Tsai HK, Urbanic JJ, Vargas CE, Yu NY, Ungar LH, Eaton E, Simone CB. PMID: 38000701.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group. Radiother Oncol. 2024 01; 190:109977. Mumaw DA, Hazy AJ, Vayntraub A, Quinn TJ, Salari K, Chang JH, Kalman N, Katz S, Urbanic J, Press RH, Thukral AD, Tsai H, Laramore GE, Molitoris J, Vargas C, Patel SH, Stevens C, Deraniyagala RL. PMID: 37922991.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro Oncol. 2023 06 02; 25(6):1123-1131. Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary JP, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. PMID: 36472389; PMCID: PMC10237411.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry. Adv Radiat Oncol. 2023 Sep-Oct; 8(5):101250. Eckstein J, Choi JI, Lozano A, Ohri N, Press R, Hasan S, Kabarriti R, Chang J, Urbanic J, Durci M, Mohammed N, Stevens C, Tsai H, Apisarnthanarax S, Regine W, Vargas C, Nichols R, Herman J, Simone CB, Chhabra A. PMID: 37408677; PMCID: PMC10318270.
      View in: PubMed   Mentions:
    8. Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 03; 21(3):297-322. Shields PG, Bierut L, Arenberg D, Balis D, Cinciripini PM, Davis J, Edmondson D, Feliciano J, Hitsman B, Hudmon KS, Jaklitsch MT, Leone FT, Ling P, McCarthy DE, Ong MK, Park ER, Prochaska J, Sandoval AJ, Sheffer CE, Spencer S, Studts JL, Tanvetyanon T, Tindle HA, Tong E, Triplette M, Urbanic J, Videtic G, Warner D, Whitlock CW, McCullough B, Darlow S. PMID: 36898367.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    9. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. JAMA Oncol. 2022 12 01; 8(12):1809-1815. Palmer JD, Klamer BG, Ballman KV, Brown PD, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. PMID: 36264568; PMCID: PMC9585461.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    10. Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical Trial. Clin Breast Cancer. 2022 12; 22(8):762-770. Hughes RT, Ip EH, Urbanic JJ, Hu JJ, Weaver KE, Lively MO, Winkfield KM, Shaw EG, Diaz LB, Brown DR, Strasser J, Sears JD, Lesser GJ. PMID: 36216768; PMCID: PMC10003823.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    11. Toward automatic beam angle selection for pencil-beam scanning proton liver treatments: A deep learning-based approach. Med Phys. 2022 Jul; 49(7):4293-4304. Kaderka R, Liu KC, Liu L, VanderStraeten R, Liu TL, Lee KM, Tu YE, MacEwan I, Simpson D, Urbanic J, Chang C. PMID: 35488864.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. In Reply to Struikmans et al. Int J Radiat Oncol Biol Phys. 2022 04 01; 112(5):1289-1290. Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, Amos RA, Bradley JA, Chen PY, Ding X, Carr AM, Taylor LM, Pankuch M, Vega RBM, Ho AY, Nyström PW, McGee LA, Urbanic JJ, Cahlon O, Maduro JH, MacDonald SM. PMID: 35286884.
      View in: PubMed   Mentions:    Fields:    
    13. CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2022 05; 23(3):e264-e268. De Ruysscher D, Ramalingam S, Urbanic J, Gerber DE, Tan DSW, Cai J, Li A, Peters S. PMID: 34489161.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    14. Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial. Adv Radiat Oncol. 2021 Sep-Oct; 6(5):100751. Parzen JS, Chuong MD, Chang J, Rosen L, Urbanic J, Hartsell W, Tsai H, Sinesi C, Zeng J, Mishra M, Vargas C, Stevens C, Kabolizadeh P. PMID: 34646969; PMCID: PMC8498730.
      View in: PubMed   Mentions: 1  
    15. Beam-Specific Spot Guidance and Optimization for PBS Proton Treatment of Bilateral Head and Neck Cancers. Int J Part Ther. 2021; 8(1):50-61. Leach K, Tang S, Sturgeon J, Lee AK, Grover R, Sanghvi P, Urbanic J, Chang C. PMID: 34285935; PMCID: PMC8270101.
      View in: PubMed   Mentions: 1  
    16. Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee. Int J Radiat Oncol Biol Phys. 2021 10 01; 111(2):337-359. Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, Amos RA, Bradley JA, Chen PY, Ding X, Carr AM, Taylor LM, Pankuch M, Vega RBM, Ho AY, Nyström PW, McGee LA, Urbanic JJ, Cahlon O, Maduro JH, MacDonald SM. PMID: 34048815; PMCID: PMC8416711.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    17. Long-Term Outcomes From a Phase 2 Trial of Radiofrequency Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2021 09 01; 111(1):152-156. Steber CR, Hughes RT, Urbanic J, Clark H, Petty WJ, Blackstock AW, Farris MK. PMID: 33932531; PMCID: PMC8559790.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    18. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2021 05 01; 110(1):206-216. Mahadevan A, Moningi S, Grimm J, Li XA, Forster KM, Palta M, Prior P, Goodman KA, Narang A, Heron DE, Lo SS, Urbanic J, Herman JM. PMID: 33358561.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    19. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group. Radiat Oncol. 2020 Nov 04; 15(1):255. Parzen JS, Hartsell W, Chang J, Apisarnthanarax S, Molitoris J, Durci M, Tsai H, Urbanic J, Ashman J, Vargas C, Stevens C, Kabolizadeh P. PMID: 33148296; PMCID: PMC7643436.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    20. Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance? J Thorac Cardiovasc Surg. 2021 09; 162(3):676-677. Bazhenova L, Urbanic J, Onaitis M. PMID: 33581906.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys. 2020 02 01; 106(2):255-260. Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. PMID: 31654784; PMCID: PMC6957747.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    22. Genome-wide enriched pathway analysis of acute post-radiotherapy pain in breast cancer patients: a prospective cohort study. Hum Genomics. 2019 06 13; 13(1):28. Lee E, Takita C, Wright JL, Slifer SH, Martin ER, Urbanic JJ, Langefeld CD, Lesser GJ, Shaw EG, Hu JJ. PMID: 31196165; PMCID: PMC6567461.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    23. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. J Clin Oncol. 2019 05 20; 37(15):1316-1325. Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, McGarry RC, Iyengar P, Pantarotto JR, Urbanic JJ, Sun AY, Daly ME, Grills IS, Sperduto P, Normolle DP, Bradley JD, Choy H. PMID: 30943123; PMCID: PMC6524984.
      View in: PubMed   Mentions: 178     Fields:    Translation:HumansCTClinical Trials
    24. Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky? Int J Radiat Oncol Biol Phys. 2019 03 15; 103(4):788-791. Palma D, Daly M, Urbanic J, Giuliani M. PMID: 30957741.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature. Int J Radiat Oncol Biol Phys. 2019 07 01; 104(3):582-589. Zhang TW, Snir J, Boldt RG, Rodrigues GB, Louie AV, Gaede S, McGarry RC, Urbanic JJ, Daly ME, Palma DA. PMID: 30630029.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansPHPublic Health
    26. Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019 04 01; 103(5):1077-1084. Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, Gopaul DD, Gomez Suescun JB, McGarry RC, Choy H, Bradley JD. PMID: 30513377; PMCID: PMC6454873.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    27. Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature. Cureus. 2018 Nov 13; 10(11):e3586. Lewis JA, Petty WJ, Urbanic J, Bernstein ED, Ahmed T. PMID: 30656089; PMCID: PMC6333266.
      View in: PubMed   Mentions: 5  
    28. Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 11 01; 102(3):527-535. Petty WJ, Urbanic JJ, Ahmed T, Hughes R, Levine B, Rusthoven K, Papagikos M, Ruiz JR, Lally BE, Chan M, Clark H, D'Agostino RB, Blackstock AW. PMID: 30003996; PMCID: PMC6743975.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    29. Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population. J Clin Oncol. 2018 08 20; 36(24):2473-2482. Hu JJ, Urbanic JJ, Case LD, Takita C, Wright JL, Brown DR, Langefeld CD, Lively MO, Mitchell SE, Thakrar A, Bryant D, Baglan K, Strasser J, Baez-Diaz L, Lesser GJ, Shaw EG. PMID: 29989859; PMCID: PMC6097833.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    30. Not All Nails Need a Hammer. Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):8. Urbanic JJ. PMID: 29619981.
      View in: PubMed   Mentions:    Fields:    
    31. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis. PLoS One. 2018; 13(4):e0195149. Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK. PMID: 29649281; PMCID: PMC5896920.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    32. Locally Advanced Lung Cancer: Is It Time to Take Cardiac Protection Seriously in Radiation Planning? Int J Radiat Oncol Biol Phys. 2018 04 01; 100(5):1091-1094. Urbanic JJ, McGarry RC, Daly ME, Palma DA. PMID: 29722650.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance). Int J Radiat Oncol Biol Phys. 2018 05 01; 101(1):177-185. Urbanic JJ, Wang X, Bogart JA, Stinchcombe TE, Hodgson L, Schild SE, Bazhenova L, Hahn O, Salgia R, Vokes EE. PMID: 29487024; PMCID: PMC6173195.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    34. The Demise of Whole-Brain Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1064-1066. Urbanic JJ. PMID: 29165277.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    35. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans. Ann Thorac Surg. 2018 Feb; 105(2):425-431. Bryant AK, Mundt RC, Sandhu AP, Urbanic JJ, Sharabi AB, Gupta S, Daly ME, Murphy JD. PMID: 29198624.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    36. The Tippy Barstool of Prophylactic Cranial Irradiation. J Oncol Pract. 2017 11; 13(11):742-743. Urbanic JJ. PMID: 29125928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    37. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017 08; 18(8):1049-1060. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. PMID: 28687377; PMCID: PMC5568757.
      View in: PubMed   Mentions: 431     Fields:    Translation:HumansCTClinical Trials
    38. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937. J Thorac Oncol. 2017 10; 12(10):1561-1570. Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD. PMID: 28648948; PMCID: PMC5610652.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    39. Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 11; 14(11):1430-1468. Shields PG, Herbst RS, Arenberg D, Benowitz NL, Bierut L, Luckart JB, Cinciripini P, Collins B, David S, Davis J, Hitsman B, Hyland A, Lang M, Leischow S, Park ER, Purcell WT, Selzle J, Silber A, Spencer S, Tanvetyanon T, Tiep B, Tindle HA, Tucker-Seeley R, Urbanic J, Hooper MW, Weksler B, Whitlock CW, Wood DE, Burns J, Scavone J. PMID: 27799513.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    40. Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505). Clin Lung Cancer. 2017 05; 18(3):333-339. Gerber DE, Urbanic JJ, Langer C, Hu C, Chang IF, Lu B, Movsas B, Jeraj R, Curran WJ, Bradley JD. PMID: 27923550; PMCID: PMC5406261.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    41. Erratum. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):638. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Choy H. PMID: 26867895.
      View in: PubMed   Mentions: 1     Fields:    
    42. Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)? Cureus. 2016 Jan 23; 8(1):e466. Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock DN, Blackstock AW, Hinson WH, Munley MT, Petty WJ, Urbanic JJ. PMID: 26929893; PMCID: PMC4764420.
      View in: PubMed   Mentions: 10  
    43. Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients. Pract Radiat Oncol. 2016 May-Jun; 6(3):e73-e80. Kilburn JM, Soike MH, Lucas JT, Ayala-Peacock D, Blackstock W, Isom S, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. PMID: 26725964; PMCID: PMC5555210.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    44. Reirradiation for second primary or recurrent cancers of the head and neck: Dosimetric and outcome analysis. Head Neck. 2016 04; 38 Suppl 1:E961-9. Garg S, Kilburn JM, Lucas JT, Randolph D, Urbanic JJ, Hinson WH, Kearns WT, Porosnicu M, Greven K. PMID: 25993910; PMCID: PMC9176709.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93(4):757-64. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Timmerman RD, Choy H. PMID: 26530743; PMCID: PMC4744654.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansCTClinical Trials
    46. Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis. J Geriatr Oncol. 2015 Mar; 6(2):119-26. Rule WG, Foster NR, Meyers JP, Ashman JB, Vora SA, Kozelsky TF, Garces YI, Urbanic JJ, Salama JK, Schild SE. PMID: 25482023; PMCID: PMC5722214.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    47. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC). Lung Cancer. 2014 Jul; 85(1):59-65. Lucas JT, Kuremsky JG, Soike M, Hinson WW, Kearns WT, Hampton CJ, Blackstock AW, Urbanic J. PMID: 24813936; PMCID: PMC9137043.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    48. Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer. J Thorac Oncol. 2014 Apr; 9(4):572-6. Kilburn JM, Lester SC, Lucas JT, Soike MH, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Munley MT, Urbanic JJ. PMID: 24736084; PMCID: PMC4075996.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    49. A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol. 2014 Sep; 16(9):1283-8. Ayala-Peacock DN, Peiffer AM, Lucas JT, Isom S, Kuremsky JG, Urbanic JJ, Bourland JD, Laxton AW, Tatter SB, Shaw EG, Chan MD. PMID: 24558022; PMCID: PMC4136890.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    50. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity? J Neurooncol. 2014 Mar; 117(1):167-74. Kilburn JM, Ellis TL, Lovato JF, Urbanic JJ, Bourland JD, Daniel Bourland J, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. PMID: 24504497; PMCID: PMC4019212.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    51. Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol. 2014 Mar; 110(3):505-10. Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, Lovato JF, Miller AA, Petty WJ, Urbanic JJ. PMID: 24444530; PMCID: PMC4006197.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    52. Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. Lung Cancer. 2013 Dec; 82(3):436-40. Salama JK, Pang H, Bogart JA, Blackstock AW, Urbanic JJ, Hogson L, Crawford J, Vokes EE. PMID: 24396884; PMCID: PMC4098705.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    53. Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery. 2013 Oct; 73(4):641-7; discussion 647. Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD. PMID: 23842552; PMCID: PMC3880778.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    54. A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. J Thorac Oncol. 2013 Aug; 8(8):1043-9. Salama JK, Hodgson L, Pang H, Urbanic JJ, Blackstock AW, Schild SE, Crawford J, Bogart JA, Vokes EE, Cancer and Leukemia Group B. PMID: 23715301; PMCID: PMC3822578.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    55. A call for the aggressive treatment of oligometastatic and oligo-recurrent non-small cell lung cancer. Pulm Med. 2012; 2012:480961. Patel PR, Yoo DS, Niibe Y, Urbanic JJ, Salama JK. PMID: 23125927; PMCID: PMC3483729.
      View in: PubMed   Mentions: 11     Fields:    
    56. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol. 2012 Dec; 110(3):381-8. Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL, Tatter SB, Shaw EG, Urbanic JJ, Chan MD. PMID: 23001361; PMCID: PMC3852435.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    57. Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0 T versus 1.5 T MRI-based treatment planning: have we finally optimised detection of occult brain metastases? J Med Imaging Radiat Oncol. 2012 Oct; 56(5):554-60. Loganathan AG, Chan MD, Alphonse N, Peiffer AM, Johnson AJ, McMullen KP, Urbanic JJ, Saconn PA, Bourland JD, Munley MT, Shaw EG, Tatter SB, Ellis TL. PMID: 23043576.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    58. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg. 2012 May; 116(5):978-83. Cochran DC, Chan MD, Aklilu M, Lovato JF, Alphonse NK, Bourland JD, Urbanic JJ, McMullen KP, Shaw EG, Tatter SB, Ellis TL. PMID: 22385005; PMCID: PMC3791504.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansPHPublic Health
    59. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e53-9. Harris S, Chan MD, Lovato JF, Ellis TL, Tatter SB, Bourland JD, Munley MT, deGuzman AF, Shaw EG, Urbanic JJ, McMullen KP. PMID: 22342297; PMCID: PMC3791505.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    60. Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular diseases or multiple sclerosis. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e519-24. Lowell D, Tatter SB, Bourland JD, deGuzman AF, Ekstrand KE, Ellis TL, Lovato JF, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Chan MD. PMID: 21601376.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    61. High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer. Lung Cancer. 2011 Dec; 74(3):384-91. Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KH. PMID: 21555162.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    62. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 2011 Jun; 114(6):1585-91. Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, Ekstrand KE, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Tatter SB. PMID: 21166567; PMCID: PMC3789371.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    63. "The best-laid plans ... often go awry ...". J Thorac Oncol. 2009 Jul; 4(7):783-4. Urbanic JJ, Lally B, Blackstock AW. PMID: 19550240.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Could it be that less is more? Lancet Oncol. 2009 May; 10(5):435-7. Lally BE, Urbanic JJ, Blackstock AW. PMID: 19410187.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer. 2009 May; 64(2):226-31. Lally BE, Geiger AM, Urbanic JJ, Butler JM, Wentworth S, Perry MC, Wilson LD, Horton JK, Detterbeck FC, Miller AA, Thomas CR, Blackstock AW. PMID: 18835059.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    66. Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone. Brachytherapy. 2008 Oct-Dec; 7(4):286-9. Rossi PJ, Urbanic J, Clark PE, McCullough DL, Lee WR. PMID: 18928924.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy. J Appl Clin Med Phys. 2008 Jun 23; 9(3):141-146. Kearns WT, Urbanic JJ, Hampton CJ, McMullen KP, Blackstock AW, Stieber VW, Hinson WH. PMID: 18716587; PMCID: PMC5722297.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    68. Small cell lung cancer: have we made any progress over the last 25 years? Oncologist. 2007 Sep; 12(9):1096-104. Lally BE, Urbanic JJ, Blackstock AW, Miller AA, Perry MC. PMID: 17914079.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    69. A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone. Am J Clin Oncol. 2007 Apr; 30(2):199-204. Papagikos MA, Rossi PJ, Urbanic JJ, deGuzman AF, McCullough DL, Clark PE, Lee WR. PMID: 17414471.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    70. Confidence intervals and survival estimates: a systematic review of 3 oncology journals. Am J Clin Oncol. 2006 Aug; 29(4):405-7. Urbanic JJ, Lee WR. PMID: 16891871.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. Update on brachytherapy in localized prostate cancer: the importance of dosimetry. Curr Opin Urol. 2006 May; 16(3):157-61. Urbanic JJ, Lee WR. PMID: 16679852.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    72. Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis. J Thorac Oncol. 2006 Feb; 1(2):112-9. Urbanic JJ, Turrisi AT, Sharma AK, Silvestri GA, Williams TE, Vanek KN, Sherman CA. PMID: 17409839.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    73. Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignancies. Semin Oncol. 2001 Jun; 28(3 Suppl 10):34-43. Rocha Lima CM, Urbanic JJ, Lal A, Kneuper-Hall R, Brunson CY, Green MR. PMID: 11510032.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    74. Docetaxel followed by gemcitabine and irinotecan in solid tumors. Oncology (Williston Park). 2001 Jan; 15(1 Suppl 1):37-45. Rocha Lima CM, Urbanic JJ, Sherman CA, Brescia FJ, Green MR. PMID: 11221020.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    James's Networks
    Concepts (226)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California